错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Cutaneous T cell lymphoma atlas reveals malignant TH2 cells supported by a B cell-rich tumor microenvironment

  • Ruoyan Li,
  • Johanna Strobl,
  • Elizabeth F. M. Poyner,
  • Aya Balbaa,
  • Fereshteh Torabi,
  • Pavel V. Mazin,
  • Nana-Jane Chipampe,
  • Emily Stephenson,
  • Ciro Ramírez-Suástegi,
  • Vijaya Baskar Mahalingam Shanmugiah,
  • Louis Gardner,
  • Bayanne Olabi,
  • Rowen Coulthard,
  • Rachel A. Botting,
  • Nina Zila,
  • Elena Prigmore,
  • Nusayhah H. Gopee,
  • Marta A. Chroscik,
  • Efpraxia Kritikaki,
  • Justin Engelbert,
  • Issac Goh,
  • Hon Man Chan,
  • Harriet F. Johnson,
  • Jasmine Ellis,
  • Victoria Rowe,
  • Win Tun,
  • Gary Reynolds,
  • Dexin Yang,
  • April Rose Foster,
  • Laure Gambardella,
  • Elena Winheim,
  • Chloe Admane,
  • Benjamin Rumney,
  • Lloyd Steele,
  • Laura Jardine,
  • Julia Nenonen,
  • Keir Pickard,
  • Jennifer Lumley,
  • Philip Hampton,
  • Simeng Hu,
  • Fengjie Liu,
  • Xiangjun Liu,
  • David Horsfall,
  • Daniela Basurto-Lozada,
  • Louise Grimble,
  • Chris M. Bacon,
  • Sophie C. Weatherhead,
  • Hanna Brauner,
  • Yang Wang,
  • Fan Bai,
  • Nick J. Reynolds,
  • Judith E. Allen,
  • Constanze Jonak,
  • Patrick M. Brunner,
  • Sarah A. Teichmann,
  • Muzlifah Haniffa

摘要

Cutaneous T cell lymphoma (CTCL) is a potentially fatal clonal malignancy of T cells primarily affecting the skin. The most common form of CTCL, mycosis fungoides, can be difficult to diagnose, resulting in treatment delay. We performed single-cell and spatial transcriptomics analysis of skin from patients with mycosis fungoides-type CTCL and an integrated comparative analysis with human skin cell atlas datasets from healthy and inflamed skin. We revealed the co-optation of T helper 2 (TH2) cell-immune gene programs by malignant CTCL cells and modeling of the tumor microenvironment to support their survival. We identified MHC-II+ fibroblasts and dendritic cells that can maintain TH2 cell-like tumor cells. CTCL tumor cells are spatially associated with B cells, forming tertiary lymphoid structure-like aggregates. Finally, we validated the enrichment of B cells in CTCL and its association with disease progression across three independent patient cohorts. Our findings provide diagnostic aids, potential biomarkers for disease staging and therapeutic strategies for CTCL.